| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| Opaleye Management Inc. | 6 | 6 | 1.18% | 2.56% | 3.21% | Q2 2015 | Q3 2016 | 6 |
| Pentwater Capital Management LP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2015 | 1 |
| Telemetry Investments, L.L.C. | 1 | 1 | 0.66% | 0.66% | 0.66% | Q2 2015 | Q2 2015 | 1 |
| WHITEBOX ADVISORS LLC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2015 | Q2 2015 | 1 |
| Context Capital Management, LLC | 1 | 1 | 1.65% | 1.65% | 1.65% | Q2 2015 | Q2 2015 | 1 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2015 | Q2 2015 | 1 |
| LAZARD ASSET MANAGEMENT LLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
| TFG Asset Management GP Ltd | 1 | 1 | 1.40% | 1.40% | 1.40% | Q2 2015 | Q2 2015 | 1 |
| NOMURA HOLDINGS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2015 | 1 |
| DEUTSCHE BANK AG\ | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2015 | 1 |
This page lists all the filers that currently own INOTEK PHARMACEUTICALS CORP or have owned INOTEK PHARMACEUTICALS CORP in the past.